| Study Number |
Title |
| 12377A |
Lymphoma Program Clinical Research Screening Protocol
|
| 09-180-A |
Ofatumumab Versus Rituximab Salvage Chemoimmunotherapy Followed By ASCT In Relapsed or Refractory DLBCL
|
| 10-064-B |
Molecular characterization of hematopoietic malignancies
|
| 10-361-B |
Prospective, Longitudinal, Multinational Registry of Patients with Newly Diagnosed Peripheral T-Cell Lymphoma
|
| 10-558-B |
Long Term Database Collection for Lymphoma
|
| 11-0027 |
A Phase III Randomized, Placebo-Controlled, Clinical Trial to Study the Safety and Efficacy of V212 in Adult Patients with Solid Tumor or Hematologic Malignancy (V212-011)
|
| 11-0601 |
Outcomes of Patients with Newly Diagnosed Peripheral T-cell Lymphoma Treated with Aggressive Chemotherapy
|
| 11-0719 |
AN OPEN-LABEL, PHASE I, DOSE-ESCALATION STUDY EVALUATING THE SAFETY AND TOLERABILITY OF GDC-0980 ADMINISTERED ONCE DAILY IN PATIENTS WITH REFRACTORY SOLID TUMORS OR NON-HODGKIN�S LYMPHOMA
|
| 11-0726 |
Significance of Positron Emission Tomography Scan in Primary Mediastinal Large B-cell Lymphoma (PMBCL) and Mediastinal GreyZone (MGZL) Lymphoma
|
| 11-0743 |
A Phase I, Open- Label, Multicenter Clinical Trial to Evaluate the
Safety and Immunogenicity of V212/Inactivated Varicella- Zoster Virus (VZV)
Vaccine in Adults with Hematologic Malignancies Receiving Treatment with
Anti- CD20 Monoclonal Antibodies (V212- 013)
|
| 12-1087 |
Comparison of Methylation Patterns By Age In Patients With Diffuse Large B-cell Lymphoma (DLBCL) and Follicular Lymphoma (FL)
|
| 12-2190 |
An Open-label, Multicenter, Single-arm, Phase 2 Study of PCI-32765 (Ibrutinib) in Subjects with Refractory Follicular Lymphoma
|
Bone